284 related articles for article (PubMed ID: 15732009)
1. Variation in antiviral 2',5'-oligoadenylate synthetase (2'5'AS) enzyme activity is controlled by a single-nucleotide polymorphism at a splice-acceptor site in the OAS1 gene.
Bonnevie-Nielsen V; Field LL; Lu S; Zheng DJ; Li M; Martensen PM; Nielsen TB; Beck-Nielsen H; Lau YL; Pociot F
Am J Hum Genet; 2005 Apr; 76(4):623-33. PubMed ID: 15732009
[TBL] [Abstract][Full Text] [Related]
2. OAS1 splice site polymorphism controlling antiviral enzyme activity influences susceptibility to type 1 diabetes.
Field LL; Bonnevie-Nielsen V; Pociot F; Lu S; Nielsen TB; Beck-Nielsen H
Diabetes; 2005 May; 54(5):1588-91. PubMed ID: 15855350
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial localization of the OAS1 p46 isoform associated with a common single nucleotide polymorphism.
Kjær KH; Pahus J; Hansen MF; Poulsen JB; Christensen EI; Justesen J; Martensen PM
BMC Cell Biol; 2014 Sep; 15():33. PubMed ID: 25205466
[TBL] [Abstract][Full Text] [Related]
4. Correlation of OAS1 gene polymorphism at exon 7 splice accepter site with interferon-based therapy of HCV infection in Pakistan.
Imran M; Manzoor S; Khattak NM; Tariq M; Khalid M; Javed F; Bhatti S
Viral Immunol; 2014 Apr; 27(3):105-11. PubMed ID: 24673406
[TBL] [Abstract][Full Text] [Related]
5. Induction and activation of antiviral enzyme 2',5'-oligoadenylate synthetase by in vitro transcribed insulin mRNA and other cellular RNAs.
Dan M; Zheng D; Field LL; Bonnevie-Nielsen V
Mol Biol Rep; 2012 Jul; 39(7):7813-22. PubMed ID: 22547268
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of a common splice site polymorphism on the generation of OAS1 variants in human bronchial epithelial cells.
Noguchi S; Hamano E; Matsushita I; Hijikata M; Ito H; Nagase T; Keicho N
Hum Immunol; 2013 Mar; 74(3):395-401. PubMed ID: 23220500
[TBL] [Abstract][Full Text] [Related]
7. 2'-5' oligoadenylate synthetase 1 polymorphism is associated with prostate cancer.
Mandal S; Abebe F; Chaudhary J
Cancer; 2011 Dec; 117(24):5509-18. PubMed ID: 21638280
[TBL] [Abstract][Full Text] [Related]
8. Long-term balancing selection at the antiviral gene OAS1 in Central African chimpanzees.
Ferguson W; Dvora S; Fikes RW; Stone AC; Boissinot S
Mol Biol Evol; 2012 Apr; 29(4):1093-103. PubMed ID: 22104212
[TBL] [Abstract][Full Text] [Related]
9. Distinct antiviral roles for human 2',5'-oligoadenylate synthetase family members against dengue virus infection.
Lin RJ; Yu HP; Chang BL; Tang WC; Liao CL; Lin YL
J Immunol; 2009 Dec; 183(12):8035-43. PubMed ID: 19923450
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the termini of the West Nile virus genome and their interactions with the small isoform of the 2' 5'-oligoadenylate synthetase family.
Deo S; Patel TR; Chojnowski G; Koul A; Dzananovic E; McEleney K; Bujnicki JM; McKenna SA
J Struct Biol; 2015 May; 190(2):236-49. PubMed ID: 25871524
[TBL] [Abstract][Full Text] [Related]
11. The role of mouse 2',5'-oligoadenylate synthetase 1 paralogs.
Elkhateeb E; Tag-El-Din-Hassan HT; Sasaki N; Torigoe D; Morimatsu M; Agui T
Infect Genet Evol; 2016 Nov; 45():393-401. PubMed ID: 27663720
[TBL] [Abstract][Full Text] [Related]
12. Impact of OAS1 Exon 7 rs10774671 Genetic Variation on Liver Fibrosis Progression in Egyptian HCV Genotype 4 Patients.
Bader El Din NG; Anany MA; Dawood RM; Ibrahim MK; El-Shenawy R; El Abd YS; El Awady MK
Viral Immunol; 2015 Nov; 28(9):509-16. PubMed ID: 26505957
[TBL] [Abstract][Full Text] [Related]
13. OAS1: a multiple sclerosis susceptibility gene that influences disease severity.
O'Brien M; Lonergan R; Costelloe L; O'Rourke K; Fletcher JM; Kinsella K; Sweeney C; Antonelli G; Mills KH; O'Farrelly C; Hutchinson M; Tubridy N
Neurology; 2010 Aug; 75(5):411-8. PubMed ID: 20679634
[TBL] [Abstract][Full Text] [Related]
14. A human cellular noncoding RNA activates the antiviral protein 2'-5'-oligoadenylate synthetase 1.
Calderon BM; Conn GL
J Biol Chem; 2018 Oct; 293(41):16115-16124. PubMed ID: 30126839
[TBL] [Abstract][Full Text] [Related]
15. Murine pancreatic beta TC3 cells show greater 2', 5'-oligoadenylate synthetase (2'5'AS) antiviral enzyme activity and apoptosis following IFN-alpha or poly(I:C) treatment than pancreatic alpha TC3 cells.
Li M; Zheng DJ; Field LL; Bonnevie-Nielsen V
Exp Diabetes Res; 2009; 2009():631026. PubMed ID: 19888425
[TBL] [Abstract][Full Text] [Related]
16. Endomembrane targeting of human OAS1 p46 augments antiviral activity.
Soveg FW; Schwerk J; Gokhale NS; Cerosaletti K; Smith JR; Pairo-Castineira E; Kell AM; Forero A; Zaver SA; Esser-Nobis K; Roby JA; Hsiang TY; Ozarkar S; Clingan JM; McAnarney ET; Stone AE; Malhotra U; Speake C; Perez J; Balu C; Allenspach EJ; Hyde JL; Menachery VD; Sarkar SN; Woodward JJ; Stetson DB; Baillie JK; Buckner JH; Gale M; Savan R
Elife; 2021 Aug; 10():. PubMed ID: 34342578
[TBL] [Abstract][Full Text] [Related]
17. Variability in the 2'-5'-oligoadenylate synthetase gene cluster is associated with human predisposition to tick-borne encephalitis virus-induced disease.
Barkhash AV; Perelygin AA; Babenko VN; Myasnikova NG; Pilipenko PI; Romaschenko AG; Voevoda MI; Brinton MA
J Infect Dis; 2010 Dec; 202(12):1813-8. PubMed ID: 21050126
[TBL] [Abstract][Full Text] [Related]
18. Single nucleotide polymorphisms in genes for 2'-5'-oligoadenylate synthetase and RNase L inpatients hospitalized with West Nile virus infection.
Yakub I; Lillibridge KM; Moran A; Gonzalez OY; Belmont J; Gibbs RA; Tweardy DJ
J Infect Dis; 2005 Nov; 192(10):1741-8. PubMed ID: 16235172
[TBL] [Abstract][Full Text] [Related]
19. Contrasted patterns of variation and evolutionary convergence at the antiviral OAS1 gene in old world primates.
Fish I; Boissinot S
Immunogenetics; 2015 Sep; 67(9):487-99. PubMed ID: 26156123
[TBL] [Abstract][Full Text] [Related]
20. OAS1 gene haplotype confers susceptibility to multiple sclerosis.
Fedetz M; Matesanz F; Caro-Maldonado A; Fernandez O; Tamayo JA; Guerrero M; Delgado C; López-Guerrero JA; Alcina A
Tissue Antigens; 2006 Nov; 68(5):446-9. PubMed ID: 17092260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
